🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Objective: The main objective is to evaluate the pattern of dual antiplate...
Status
Unknown
Location
Hospital Germans Trias i Pujol
Start Date
2010-06
Trial ID
NCT01141153
Treatments Being Tested
The goal of this clinical trial is to compare two treatment regimes, namely...
Status
Recruiting
Location
Tata Memorial Centre
Start Date
2024-03-07
Trial ID
NCT06214572
Open-Label Phase 3 study to evaluate the long-term safety and efficacy of u...
Status
Completed
Location
Warner Chilcott Investigational Site
Start Date
2010-01
Trial ID
NCT01065012
A Phase I, Single Center, Randomized, Double-blind, Placebo-controlled, Sin...
Status
Completed
Location
The First Hospital of Jilin University
Start Date
2019-03-06
Trial ID
NCT03903081
Treatments Being Tested
In recent years, diabetes has emerged as one of the most significant co-dis...
Status
Completed
Location
Children's Hospital of Philadelphia and University of Pennsylvania
Start Date
2013-06
Trial ID
NCT01879228
Treatments Being Tested
In this phase II trial, the investigators overarching goal is to demonstrat...
Status
Recruiting
Location
University of Washington
Start Date
2022-11-27
Trial ID
NCT05340465
Treatments Being Tested
Motor fluctuations are identified as the most challenging symptoms by parki...
Status
Not Yet Recruiting
Location
CHU Toulouse
Start Date
2025-05-01
Trial ID
NCT06817200
Treatments Being Tested
The purpose of this study is to assess if a zoledronic acid injection can a...
Status
Terminated
Location
University of Calgary
Start Date
2023-05-16
Trial ID
NCT05204836
Treatments Being Tested
The study proposes to evaluate the safety, tolerability, and efficacy of PD...
Status
Terminated
Location
Mount Sinai School Of Medicine/Mount Sinai Medical Center
Start Date
2013-03-15
Trial ID
NCT01732211
Treatments Being Tested